Table 2 Correlation between CDC20 expression and the clinicopathological characteristics of colorectal cancer patients
From: CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
| Characteristics | CDC20 | Chi-square | ||
|---|---|---|---|---|
| Low or none | High | |||
| No. cases (%) | No. cases (%) | testP-value | ||
| Gender | Female | 39 (30.0) | 47 (41.2) | 0.067 |
| Male | 91 (70.0) | 67 (58.8) | ||
| Age (years) | ≤ 50 | 43 (33.1) | 42 (36.8) | 0.538 |
| > 50 | 87 (66.9) | 72 (63.2) | ||
| Location | colon | 61 (46.9) | 52 (45.6) | 0.838 |
| rectal | 69 (53.1) | 62 (54.4) | ||
| Clinical Stage | I | 26 (20.0) | 16 (14.0) | 0.008 |
| II | 37 (28.5) | 16 (14.0) | ||
| III | 35 (26.9) | 37 (32.5) | ||
| IV | 32 (24.6) | 45 (39.5) | ||
| T classification | T1+T2 | 29 (22.3) | 27 (23.7) | 0.799 |
| T3+T4 | 101 (77.7) | 87 (76.3) | ||
| N classification | No | 66 (50.8) | 41 (36.0) | 0.020 |
| Yes | 64 (49.2) | 73 (64.0) | ||
| M classification | M0 | 98 (75.4) | 69 (60.5) | 0.013 |
| M1 | 32 (24.6) | 45 (39.5) | ||
| Pathologic Differentiation | Poor | 21 (16.2) | 34 (29.8) | 0.008 |
| Moderate | 93 (71.5) | 75 (65.8) | ||
| Well | 16 (12.3) | 5 (4.4) | ||
|
Vital status (as followed up) | Alive | 91 (70.0) | 51 (44.7) | <0.001 |
| Dead | 39 (30.0) | 63 (55.3) | ||